1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in Asia-Pacific

Biotechnology in Asia-Pacific

  • January 2016
  • -
  • MarketLine
  • -
  • 34 pages

Introduction

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Asia-Pacific biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The Asia-Pacific biotechnology market is expected to generate total revenues of $88.6bn in 2015, representing a compound annual growth rate (CAGR) of 6.7% between 2011 and 2015.

- The medical/healthcare segment is expected to be the market's most lucrative in 2015, with total revenues of $47.8bn, equivalent to 54% of the market's overall value

- China has thrown significant investment at the biotechnology industry, which should deliver healthy future growth, having already had some success with developing innovative advances. For example, SiBono Genetech Ltd was the first company in the world to receive regulatory approval for gene therapy and Sinovac Biotech was the first company in the world to conduct phase one trials on a SARS vaccine.

Features

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts

- Macroeconomic indicators provide insight into general trends within the Asia-Pacific economy

Key Questions Answered

- What was the size of the Asia-Pacific biotechnology market by value in 2015?

- What will be the size of the Asia-Pacific biotechnology market in 2020?

- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Asia-Pacific's biotechnology market?

Table Of Contents

Biotechnology in Asia-Pacific
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Astellas Pharma Inc. 19
Merck and Co., Inc. 22
Mitsubishi Tanabe Pharma Corporation 25
Takeda Pharmaceutical Company Limited 28
Methodology 31
Industry associations 32
Related MarketLine research 32
Appendix 33
About MarketLine 33

List of Tables
Table 1: Asia-Pacific biotechnology industry value: $ billion, 2011-15(e)
Table 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2015(e)
Table 3: Asia-Pacific biotechnology industry geography segmentation: $ billion, 2015(e)
Table 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2015-20
Table 5: Astellas Pharma Inc.: key facts
Table 6: Astellas Pharma Inc.: key financials ($)
Table 7: Astellas Pharma Inc.: key financials (Â¥)
Table 8: Astellas Pharma Inc.: key financial ratios
Table 9: Merck and Co., Inc.: key facts
Table 10: Merck and Co., Inc.: key financials ($)
Table 11: Merck and Co., Inc.: key financial ratios
Table 12: Mitsubishi Tanabe Pharma Corporation: key facts
Table 13: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (Â¥)
Table 15: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 16: Takeda Pharmaceutical Company Limited: key facts
Table 17: Takeda Pharmaceutical Company Limited: key financials ($)
Table 18: Takeda Pharmaceutical Company Limited: key financials (Â¥)
Table 19: Takeda Pharmaceutical Company Limited: key financial ratios

List of Figures
Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2011-15(e)
Figure 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2015(e)
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2015(e)
Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2015
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2015
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2015
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2015
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2015
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2015
Figure 11: Astellas Pharma Inc.: revenues and profitability
Figure 12: Astellas Pharma Inc.: assets and liabilities
Figure 13: Merck and Co., Inc.: revenues and profitability
Figure 14: Merck and Co., Inc.: assets and liabilities
Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues and profitability
Figure 16: Mitsubishi Tanabe Pharma Corporation: assets and liabilities
Figure 17: Takeda Pharmaceutical Company Limited: revenues and profitability
Figure 18: Takeda Pharmaceutical Company Limited: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...

Sample Preparation Market by Product , Consumables ), Application , End Users  - Global Forecast to 2021

Sample Preparation Market by Product , Consumables ), Application , End Users - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves ...

Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

Trends In Gene Therapy

July 2016 $ 5 000

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.